Nurturing an idea and launching a business is only half of the story. Indeed, scaling an innovation is more challenging as it requires a fit-for-purpose approach. As Steve Blank puts it in its Wicked Entrepreneurship Class, ”there are no facts inside the building, so get the heck out”.

At Civanca, we encourage and promote the idea of Building a strong inner circle. So, we were thrilled to listen to and mingle with aspiring entrepreneurs and seasoned founders at the Imperial White City event hosted by Imperial Enterprise Lab & Giant Ventures.

 

The New Rules of Entrepreneurship: Where Science Meets Scale
When I walked into Scale Space on Imperial’s White City campus for the Scaling Science summit, I expected another academic talk. What I got was a masterclass in turning lab breakthroughs into market-shaking ventures – and a front-row seat to London’s rising status as a deep-tech powerhouse. Here’s why this event left me (and 50+ researchers) buzzing with entrepreneurial energy.

The Vibe: Where Lab Coats Meet Term Sheets

Scale Space’s glass-and-steel atrium – set the tone. With 70+ science-led ventures buzzing in the building, even the coffee line felt charged with serendipity. Giant Ventures’ recent $250M climate/health fund announcement added fuel to the fire – you could practically smell the ambition in the air.

Fireside Chat: Terry Rudolph’s Quantum Leap from Lab to $6B Unicorn

The PsiQuantum co-founder dropped truth bombs on bridging academia and Silicon Valley:

• “Investors don’t buy science -they buy your ability to execute.”
  (His “overnight success” took 11 years and 83 pitch iterations.)
• “Speak their language.”
  Tailor every deck: VCs want ROI, governments want jobs, pharma wants IP.

Rudolph’s takeaway? Persistence > Genius in deep tech.

Panel Spotlight: Three Scientists Who Cracked the Code

1. Anna-Luisa Schaffgotsch (Impli)
   Bayer’s 2024 partnership validated her implantable hormone sensor.
   Clinician’s edge: “Solve the pain point you’ve lived – mine was IVF’s diagnostic delays.”
2. Glen Gowers (Basecamp Research)
   Raised $60M to build biology’s “GPT” via biodiversity data.
   Data rule: “Move fast, decide often—1% of choices drive 99% of outcomes.”
3. Simon Hunter (Hinge Health)
   Prepping for 2025 NYSE IPO after cracking US scale.
   Transatlantic truth: “UK investors obsess over patents. US investors ask: ‘Can you own this market in 18 months?’”

5 Rules I’m Stealing from Imperial’s Entrepreneur Elite

1. Pitch the person, not the product
   Customize decks like Rudolph’s 83 versions.
2. Velocity > Novelty
   Gowers: “Investors pay for your speed, not your arXiv citations.”
3. Geography is strategy
   Hunter: “EU diligence = ‘Prove the science.’ US = ‘Prove the TAM.’”
4. Mentor with purpose
   Schaffgotsch: “Only take advice from people who’ve built your type of company.”
5. Fail small, win big
   Gowers: “Make 100 quick decisions—5 will matter.”

 

Final Thought
As I left, Simon Hunter’s words stuck: “The best companies aren’t built by the smartest founders – they’re built by the most stubborn.” Whether you’re prototyping in a White City lab or scribbling ideas in a lecture hall, remember: London’s deep-tech ecosystem is hungry for your stubbornness.

 

By Tenghis Sukhbaatar, Medical Student & intercalating Bioengineering student